Genetic Technologies (GENE) - Operating Margin

Genetic Technologies

GENE

#9900

Rank

₹0.31 B

Marketcap

🇦🇺 Australia

Country

₹64.55

Share price

0.00%

Change (1 day)

-78.17%

Change (1 year)

⚕️ Diagnostics and Testing 🧬 Biotech

Operating Margin history for Genetic Technologies from 2004 to 2008

Operating Margin at the end of each year

Year	Operating Margin	Change
2023	-137.11%	30.06%
2022	-105.42%	-98.2%
2021	-5,870.91%	-90.8%
2020	-63,815.64%	152.7%
2019	-25,253.91%	774.73%
2018	-2,887.06%	78.13%
2017	-1,620.78%	57.99%
2016	-1,025.84%	134.26%
2015	-437.90%	97.22%
2014	-222.04%	-19.8%
2013	-276.84%	92.92%
2012	-143.50%	-849.47%
2011	19.15%	-109.6%
2010	-199.40%	175.78%
2009	-72.30%	106.56%
2008	-35.00%	235.52%
2007	-10.43%	-80.57%
2006	-53.71%	-29.66%
2005	-76.35%	-57.62%
2004	-180.17%	895.39%
2003	-18.10%	-93.76%
2002	-289.92%	19.06%
2001	-243.50%

Operating Margin for similar companies or competitors

Company	Operating Margin	Operating Margin differencediff.	Country
Eterna Therapeutics ERNA	-13,396.30%	9,671.19%	🇺🇸 USA
Myriad Genetics MYGN	-20.72%	-84.89%	🇺🇸 USA
LabCorp LH	4.67%	-103.41%	🇺🇸 USA
Quest Diagnostics DGX	11.66%	-108.50%	🇺🇸 USA
Compugen CGEN	12.56%	-109.16%	🇮🇱 Israel
Danaher DHR	21.11%	-115.40%	🇺🇸 USA
Thermo Fisher Scientific TMO	16.19%	-111.81%	🇺🇸 USA
Neogen NEOG	-3.46%	-97.48%	🇺🇸 USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Operating Margin for Genetic Technologies (GENE)

Operating Margin as of November 2024 (TTM): -137.10%